200
Participants
Start Date
January 31, 2023
Primary Completion Date
March 29, 2030
Study Completion Date
July 11, 2030
RECRUITING
New York University, New York
RECRUITING
Centro Cardiologico Monzino, Milan
RECRUITING
John Hopkins University School of Medicine, Baltimore
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Hôpital Haut-Lévêque, Pessac
RECRUITING
Nantes University Hospital, Nantes
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
University Hospital Muenster, Münster
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Pitié-Salpêtrière Hospital, Paris
RECRUITING
University of Colorado, Denver, Aurora
RECRUITING
University of California San Francisco, San Francisco
RECRUITING
Wuerzburg University Hospital, Würzburg
RECRUITING
Brigham and Women's Hospital, Boston
RECRUITING
Hopital Louis Pradel, Bron
RECRUITING
Istituti Clinici Scientifici Maugeri SpA, Pavia
RECRUITING
Skåne University Hospital, Malmo
RECRUITING
The Queen Elizabeth Hospital, Glasgow
RECRUITING
Barts & The London Health NHS Trust, London
RECRUITING
St. George's University Hospitals NHS Foundation Trust, London
RECRUITING
Royal Brompton & Harefield NHS Foundation Trust, London
Lead Sponsor
Collaborators (1)
University of California, San Francisco
OTHER
Brigham and Women's Hospital
OTHER
New York University
OTHER
University of Colorado, Denver
OTHER
Johns Hopkins University
OTHER
The Cleveland Clinic
OTHER
Mayo Clinic
OTHER
Medical University of South Carolina
OTHER
Hopital Louis Pradel
OTHER
Istituti Clinici Scientifici Maugeri SpA
OTHER
The Queen Elizabeth Hospital
OTHER
St George's University Hospitals NHS Foundation Trust
OTHER
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Barts & The London NHS Trust
OTHER
Skane University Hospital
OTHER
Centro Cardiologico Monzino
OTHER
Hôpital Haut-Lévêque
OTHER
Nantes University Hospital
OTHER
Pitié-Salpêtrière Hospital
OTHER
Wuerzburg University Hospital
OTHER
University Hospital Muenster
OTHER
Tenaya Therapeutics
INDUSTRY